{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:06:39Z","timestamp":1769598399775,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med"],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.1007\/bf00879658","type":"journal-article","created":{"date-parts":[[2004,12,25]],"date-time":"2004-12-25T17:31:30Z","timestamp":1103995890000},"page":"722-727","source":"Crossref","is-referenced-by-count":5,"title":["The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer"],"prefix":"10.1007","volume":"24","author":[{"given":"V.","family":"Roelants","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"De Nayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9343(81)90368-5","volume":"71","author":"MW Ashcraft","year":"1981","unstructured":"Ashcraft MW, Van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total scan in the follow-up study of patients with treated differentiated thyroid cancer.Am J Med 1981; 71: 807?814.","journal-title":"Am J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0002-9343(80)90011-X","volume":"69","author":"MA Charles","year":"1980","unstructured":"Charles MA, Dodson LE, Waldeck N, et al. Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma.Am J Med 1980; 69: 401?407.","journal-title":"Am J Med"},{"key":"CR3","first-page":"107","volume":"13","author":"EG Black","year":"1987","unstructured":"Black EG, Sheppard MC, Hoffenberg R. Serial serum thyroglobulin measurement in the management of differentiated thyroid carcinoma.Clin Endocrinol 1987; 13: 107?110.","journal-title":"Clin Endocrinol"},{"key":"CR4","first-page":"340","volume":"28","author":"JH Bolk","year":"1985","unstructured":"Bolk JH, Bussemaker JK, Nieuwenhuizen Kruseman AC, De Vijlder JIM, Goslings BM. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake and total body scans.Neth J Med 1985; 28: 340?346.","journal-title":"Neth J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1210\/jcem-53-6-1199","volume":"53","author":"AB Schneider","year":"1981","unstructured":"Schneider AB, Line BR, Goldman JM, Robbins J. Sequential serum thyroglobulin determinations,131I scans, and131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer.J Clin Endocrinol Metab 1981; 53: 1199?1206.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR6","first-page":"98","volume":"79","author":"M Ozata","year":"1994","unstructured":"Ozata M, Suzuki S, Miyamoto T, Tsuan Liu R, Fierro-Renoy F, Degroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.J Clin Endocrinol Metab 1994; 79: 98?105.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR7","first-page":"1766","volume":"31","author":"G Ronga","year":"1990","unstructured":"Ronga G, Fiorentino A, Pasorio E, et al. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?J Nucl Med 1990; 31: 1766?1771.","journal-title":"J Nucl Med"},{"key":"CR8","first-page":"446","volume":"37","author":"M Franceschi","year":"1996","unstructured":"Franceschi M, Kusic Z, Franceschi D, Lukinac L, Roncevic S. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.J Nucl Med 1996; 37: 446?451.","journal-title":"J Nucl Med"},{"key":"CR9","first-page":"474","volume-title":"Thyroid diseases. Clinical fundamentals and therapy","author":"C Beckers","year":"1993","unstructured":"Beckers C. How to treat thyroid cancer after surgery? In: Monaco F, Satta M, Shapiro B, Troncone L, eds. Thyroid diseases. Clinical fundamentals and therapy. Boca Raton: CRC Press; 1993: 474?475."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02262724","volume":"18","author":"M Schlumberger","year":"1991","unstructured":"Schlumberger M, Fragu P, Gardet P, Lumbroso J, Violot D, Parmentier C. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.Eur J Nucl Med 1991; 18: 153?157.","journal-title":"Eur J Nucl Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/sim.4780050105","volume":"5","author":"W Rindskopf","year":"1986","unstructured":"Rindskopf W, Rindskopf R. The value of latent class analysis in medical diagnosis.Stat Med 1986; 5: 21?27.","journal-title":"Stat Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/sim.4780070703","volume":"7","author":"NJ Nagelkerke","year":"1988","unstructured":"Nagelkerke NJ, Fidler V, Buwalda M. Instrumental variables in the evaluation of diagnostic test procedures when the true disease state is unknown.Stat Med 1988; 7: 739?744.","journal-title":"Stat Med"},{"key":"CR13","first-page":"167","volume":"36","author":"W Huis","year":"1996","unstructured":"Huis W. Estimating the error rates of diagnostic tests.Biometrics 1996; 36: 167?171.","journal-title":"Biometrics"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2307\/2533043","volume":"52","author":"Y Qu","year":"1996","unstructured":"Qu Y, Tan M, Kutner MH. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests.Biometrics 1996; 52: 797?820.","journal-title":"Biometrics"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jcem.80.5.7744990","volume":"80","author":"EL Mazzaferri","year":"1995","unstructured":"Mazzaferri EL. Editorial: treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?J Clin Endocrinol Metab 1995; 80: 1485?1487.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0889-8529(18)30020-3","volume":"24","author":"KB Ain","year":"1995","unstructured":"Ain KB. Papillary thyroid carcinoma: etiology, assessment and therapy.Endocrinol Metab Clin North Am 1995; 24: 711?759.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0889-8529(18)30021-5","volume":"24","author":"SK Grebe","year":"1995","unstructured":"Grebe SK, Hay ID. Follicular thyroid cancer.Endocrinol Metab Clin North Am 1995; 24: 761?801.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.Am J Med 1994; 97: 418?428.","journal-title":"Am J Med"},{"key":"CR19","first-page":"714","volume":"75","author":"SA Samaan","year":"1992","unstructured":"Samaan SA, Schultz PN, Hickey RC, Goepfert H, Johnston DA, Ordonnez NG. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients.J Clin Endocrinol Metab 1992; 75: 714?720.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00209000","volume":"20","author":"S Bakheet","year":"1993","unstructured":"Bakheet S, Hammami SM. False-positive thyroid cancer metastasis and whole-body radioiodine scanning due to retained radioactivity in the oesophagus.Eur J Nucl Med 1993; 20: 415?419.","journal-title":"Eur J Nucl Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/thy.1995.5.165","volume":"5","author":"B Schaadt","year":"1995","unstructured":"Schaadt B, Feldt-Rasmusson U, Rasmusson B, et al. Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma.Thyroid 1995; 5: 165?170.","journal-title":"Thyroid"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00006231-198804000-00002","volume":"9","author":"E Moser","year":"1988","unstructured":"Moser E, Fritsch S, Braun S. Thyroglobulin and I-131 uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.Nucl Med Commun 1988; 9: 262?266.","journal-title":"Nucl Med Commun"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/acta.0.0980215","volume":"98","author":"M Schlumberger","year":"1981","unstructured":"Schlumberger M, Fragu P, Parmentier C, Tubiana M. Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma: comparison of its value in patients with or without normal residual tissue.Acta Endocrinol (Copenh) 1981; 98: 215?221.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4899-1245-9_45","volume-title":"Iodine deficiency in Europe: a continuing concern","author":"C Beckers","year":"1993","unstructured":"Beckers C, Ermans A, De Nayer P, et al. Status of iodine nutrition and thyroid function in Belgium. In: Delange F, Dunn JT, Glinoer D, eds.Iodine deficiency in Europe: a continuing concern. New York: Plenum Press; 1993: 359?362."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bjc.1985.225","volume":"52","author":"CJ Edmonds","year":"1985","unstructured":"Edmonds CJ, Kermode JC. Thyrotropin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.Br J Cancer 1985; 52: 537?541.","journal-title":"Br J Cancer"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/1097-0142(19880301)61:5<976::AID-CNCR2820610520>3.0.CO;2-U","volume":"61","author":"HW M\u00fcller-Gartner","year":"1988","unstructured":"M\u00fcller-Gartner HW, Schneider C. Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer.Cancer 1988; 61: 976?981.","journal-title":"Cancer"},{"key":"CR27","first-page":"9","volume":"28","author":"N Panza","year":"1984","unstructured":"Panza N, Lombardi G, Minozzi M, et al. I-131 total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma.J Nucl Med All Sci 1984; 28: 9?12.","journal-title":"J Nucl Med All Sci"},{"key":"CR28","first-page":"1488","volume":"80","author":"J Pineda","year":"1995","unstructured":"Pineda J, Lee T, Ain K, Reynolds J, Robbins J. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.J Clin Endocrinol Metab 1995; 80: 1488?1492.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/thy.1994.4.501","volume":"4","author":"OH Clark","year":"1994","unstructured":"Clark OH, Hoelting T. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans.Thyroid 1994; 4: 501?505.","journal-title":"Thyroid"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2265.1980.tb01057.x","volume":"13","author":"U Feldt-Rasmusen","year":"1980","unstructured":"Feldt-Rasmusen U, Petersen PH, Date J. Half-life of Tg from plasma. Letter to the editors.Clin Endocrinol 1980; 13: 303?304.","journal-title":"Clin Endocrinol"}],"container-title":["European Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00879658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00879658\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00879658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T12:57:50Z","timestamp":1556542670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00879658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["BF00879658"],"URL":"https:\/\/doi.org\/10.1007\/bf00879658","relation":{},"ISSN":["0340-6997","1619-7089"],"issn-type":[{"value":"0340-6997","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}